Chugai Pharmaceutical Co. Ltd.

In News

Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control - TipRanks

TipRanks - Apr 01, 2026

Chugai Pharmaceutical (OTCMKTS:CHGCY) Sees Unusually-High Trading Volume - Here's What Happened - MarketBeat

MarketBeat - Mar 31, 2026

AWS Collaborates with Chugai Pharmaceutical Co. on Quantum-Inspired and Constraint Programming Methods for Cyclic Peptide-Protein Docking - Amazon Web Services (AWS)

Amazon Web Services (AWS) - Oct 13, 2025

Jan 29,2026 | Chugai Relocates Head Office | News | CHUGAI PHARMACEUTICAL CO., LTD. - chugai-pharm.co.jp

chugai-pharm.co.jp - Jan 29, 2026

Rani Therapeutics signs up to $1.09 billion licensing deal with Japan's Chugai Pharma - reuters.com

reuters.com - Oct 17, 2025

Celiac Disease Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | AMYRA Biotech AG, Equillium Bio., Chugai Pharmaceutical Co., Ltd., Calypso - barchart.com

barchart.com - Mar 30, 2026

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st

simplywall.st - Feb 01, 2026

Chugai Pharmaceutical Co., Ltd. (CHGCY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - seekingalpha.com

seekingalpha.com - Jan 15, 2026

Stock List: Research Stocks from Around the World - gurufocus.com

gurufocus.com - Mar 28, 2026

Chugai Pharmaceutical Hits Day Low of JPY 7,946 Amid Price Pressure - Markets Mojo

Markets Mojo - Mar 31, 2026

Chugai and Gero Enter into Joint Research and License - globenewswire.com

globenewswire.com - Jul 07, 2025

Chugai Slides After Ending Trials for Muscle Disorder Drug - Bloomberg.com

Bloomberg.com - Mar 22, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment